Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Safety & Efficacy of Zirconium Silicate in Mild to Moderate Hyperkalemia

ClinicalTrials.gov ID: NCT01737697

Public ClinicalTrials.gov record NCT01737697. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 4:52 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Multicenter, Two-phase, Multi-dose, Prospective, Randomized, Double-blind, Placebo-Controlled Study of Safety and Efficacy of Microporous, Fractionated, Protonated Zirconium Silicate in Mild to Moderate Hyperkalemia

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Acute Phase: It is hypothesized that ZS (zirconium silicate) is more effective than placebo control (alternative hypothesis) in lowering S-K levels in subjects with S-K between 5.0 - 6.5 mmol/l versus no difference between ZS and placebo control (null hypothesis). Subacute Phase (randomized withdrawal): It is hypothesized that ZS once daily is more effective than placebo control (alternative hypotheses) in maintaining normokalemic levels (3.5 - 4.9 mmol/l) among subjects completing the Acute Phase versus no difference between each ZS dose and respective placebo controls (null hypotheses).

Study identification

NCT ID
NCT01737697
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
ZS Pharma, Inc.
Industry
Enrollment
754 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 30, 2012 (Actual)
Primary completion
Oct 31, 2013 (Actual)
Completion
Nov 30, 2013 (Actual)
Last update posted
Oct 12, 2018

2012 – 2013

United States locations

U.S. sites
42
U.S. states
17
U.S. cities
40
Facility City State ZIP Site status
Pinnacle Research Group Anniston Alabama 36207 —
Saadat Ansari Internal Medicine Huntsville Alabama 35801 —
Aspire Clinical Studies, LLC Glendale Arizona 85301 —
Southwest Clinical Research Institute Tempe Arizona 85284 —
California Institute of Renal Research Chula Vista California 91910 —
Torrance Clinical Research Lomita California 90717 —
Academic Medical Research Institute Los Angeles California 90022 —
Mohammad Ismail, Inc Paramount California 90723 —
Apex Research of Riverside Riverside California 92505 —
Capital Nephrology Clinical Group Sacramento California 95825 —
Pikes Peak Nephrology Associates Colorado Springs Colorado 80909 —
Denver Nephrologists, PC Denver Colorado 80230 —
Nephrology and Hypertension Associates Middlebury Connecticut 06762 —
JEM Research Institute Atlantis Florida 33462 —
Clinical Research of Brandon Brandon Florida 33511 —
Meridien Research Brooksville Florida 34601 —
Riverside Clinical Research Edgewater Florida 32123 —
Endocrinology of Central Florida Lake Mary Florida 32746 —
Meridien Research Lakeland Florida 33805 —
San Marcus Research Clinic Miami Florida 33015 —
Medical Consulting Center Miami Florida 33125 —
Elite Research Institute Miami Florida 33169 —
Prevention & Strengthening Solutions, Inc Miramar Florida 33023 —
PCCC of Volusia New Smyrna Beach Florida 32168 —
Meridien Research St. Petersburg Florida 33709 —
Lakeview Medical Research Summerfield Florida 34491 —
Clinical Research Trials of Florida Tampa Florida 33607 —
Metabolic Research Institute West Palm Beach Florida 33401 —
Research by Design Evergreen Park Illinois 60805 —
Professional Research Network of Kansas, LLC Wichita Kansas 67213 —
Washington Nephrology Associates Bethesda Maryland 20814 —
Nephrology Center DBA, Paragon Health PC Kalamazoo Michigan 49007 —
The Center for Clinical Trials Biloxi Mississippi 39531 —
Clinical Research Consultants, LLC Kansas City Missouri 64111 —
United Medical Associates Binghamton New York 13903 —
Life Medi-Research and Management Brooklyn New York 11206 —
Doylestown Hospital Medical Research Doylestown Pennsylvania 18901 —
South Carolina Nephrology & Hypertension Orangeburg South Carolina 29118 —
Carolina Diabetes and Kidney Center Sumter South Carolina 29150 —
Southwest Houston Research, Ltd Houston Texas 77099 —
Clinical Advancement Center, PLLC San Antonio Texas 78215 —
Southern Utah Kidney and Hypertension Center St. George Utah 84770 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01737697, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 12, 2018 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01737697 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →